Adenovirus E1A-Regulated Transcription Factor p120^E4F Inhibits Cell Growth and Induces the Stabilization of the cdk Inhibitor p21^WAF1

REFERENCES

• Agrawal, D., F. Dong, Y. Z. Wang, D. Kayda, and W. J. Pledger 1995. Regulation of cyclin E and p27kip during mitosis in BALB/c 3T3 cells. Cell Growth Differ. 6: 1199–1205.
   PubMedGoogle Scholar
• Alessandrini, A., D. S. Chiaur, and M. Pagano 1997. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11: 342–345.
   PubMedGoogle Scholar
• Berk, A. J. 1986. Functions of adenovirus E1A. Cancer Surv. 5: 367–387.
   PubMedGoogle Scholar
• Blagosklonny, M. V., G. S. Wu, S. Omura, and W. S. el-Deiry 1996. Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem. Biophys. Res. Commun. 227: 564–569.
   PubMed Web of Science ®Google Scholar
• Botchan, M. 1996. Coordinating DNA replication with cell division: current status of the licensing concept. Proc. Natl. Acad. Sci. USA 93: 9997–10000.
   PubMedGoogle Scholar
• Chevalier, S., and J. J. Blow 1996. Cell cycle control of replication initiation in eukaryotes. Curr. Opin. Cell Biol. 8: 815–821.
   PubMedGoogle Scholar
• Chomczynski, P., and N. Sacchi 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156–159.
   PubMed Web of Science ®Google Scholar
• Clurman, B. E., R. J. Sheaff, K. Thress, M. Groudine, and J. M. Roberts 1996. Turnover of cyclin E by the ubiquitin-proteosome pathway is regulated by cdk2 binding and phosphorylation. Genes Dev. 10: 1979–1990.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., P. P.-C. Hu, T. F. Kowalik, J. Yingling, and X.-F. Wang 1997. The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol. 17: 2030–2037.
   PubMedGoogle Scholar
• Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X. F. Wang 1995. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92: 5545–5549.
   PubMed Web of Science ®Google Scholar
• Doree, M., and S. Galas 1994. The cyclin-dependent protein kinases and the control of cell division. FASEB J. 8: 1114–1121.
   PubMed Web of Science ®Google Scholar
• Eckner, R. 1996. p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol. Chem. 377: 685–688.
   PubMedGoogle Scholar
• el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E. 1996. p53-dependent repression of cdk4 synthesis in transforming growth factor-beta-induced G1 cell cycle arrest. J. Lab. Clin. Med. 128: 355–360.
   PubMedGoogle Scholar
• Fernandes, E. R., and C. L. Ashendel 1996. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts. Mol. Carcinog. 17: 23–34.
   PubMedGoogle Scholar
• Fernandes, E. R., and R. J. Rooney. Unpublished data.
   Google Scholar
• Fernandes, E. R., and R. J. Rooney 1997. The adenovirus E1A-regulated transcription factor E4F is generated from the human homolog of nuclear factor φAP3. Mol. Cell. Biol. 17: 1890–1903.
   PubMedGoogle Scholar
• Fognani, C., G. Della Valle, and L. E. Babiss 1993. Repression of adenovirus E1A enhancer activity by a novel zinc finger-containing DNA-binding protein related to the GLI-Kruppel protein. EMBO J. 12: 4985–4992.
   PubMedGoogle Scholar
• Gunning, P., J. Leavitt, G. Muscat, S.-Y. Ng, and L. Kedes 1987. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84: 4831–4835.
   PubMed Web of Science ®Google Scholar
• Harlow, E., and D. Lane 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Hengst, L., and S. I. Reed 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861–1864.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., C. A. Finlay, R. S. Quartin, S. J. Baker, E. R. Fearon, B. Vogelstein, and A. J. Levine 1990. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the “hot spot” mutant phenotypes. Cell Growth Differ. 1: 571–580.
   PubMedGoogle Scholar
• Jacks, T., and R. A. Weinberg 1996. Cell-cycle control and its watchman. Nature 381: 643–644.
   PubMed Web of Science ®Google Scholar
• Jones, N. C. 1990. Transformation by the human adenoviruses. Semin. Cancer Biol. 1: 425–435.
   PubMedGoogle Scholar
• Jones, N. C. 1995. Transcriptional modulation by the adenovirus E1A gene. Curr. Top. Microbiol. Immunol. 199: 59–80.
   PubMedGoogle Scholar
• King, R. W., R. J. Deshaies, J. Peters, and M. W. Kirschner 1996. How proteolysis drives the cell cycle. Science 274: 1652–1659.
   PubMed Web of Science ®Google Scholar
• Krishan, A. 1975. Rapid flow cytometric analysis of the mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66: 188–193.
   PubMed Web of Science ®Google Scholar
• Landers, J. E., D. S. Haines, Strauss J. F., III, and D. L. George 1994. Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 9: 2745–2750.
   PubMed Web of Science ®Google Scholar
• Lennon, G., C. Auffray, M. Polymeropoulos, and M. B. Soares 1996. The I.M.A.G.E. consortium: an integrated molecular analysis of genomes and their expression. Genomics 33: 151–152.
   PubMed Web of Science ®Google Scholar
• Li, J.-M., M. A. Nichols, S. Chandrasekharan, Y. Xiong, and X.-F. Wang 1995. Transforming growth factor B activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270: 26750–26753.
   PubMed Web of Science ®Google Scholar
• Lin, J., A. K. Teresky, and A. J. Levine 1995. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 10: 2387–2390.
   PubMed Web of Science ®Google Scholar
• Maki, C. G., and P. M. Howley 1997. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell. Biol. 17: 355–363.
   PubMed Web of Science ®Google Scholar
• Mal, A., R. Y. Poon, P. H. Howe, H. Toyoshima, T. Hunter, and M. L. Harter 1996. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells. Nature 380: 262–265.
   PubMedGoogle Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Kato 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066–2076.
   PubMed Web of Science ®Google Scholar
• Nevins, J. R. 1995. Adenovirus E1A: transcription regulation and alteration of cell growth control. Curr. Top. Microbiol. Immunol. 199: 25–32.
   PubMedGoogle Scholar
• Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682–685.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis 1989. Molecular cloning: a laboratory manual2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Santos, E., S. R. Tronick, S. A. Aaronson, S. Pulcianni, and M. Barbacid 1982. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB and Harvey-MSV transforming genes. Nature 298: 343–347.
   PubMed Web of Science ®Google Scholar
• Schwaller, J., H. P. Koeffler, G. Niklaus, P. Loetscher, S. Nagel, M. F. Fey, and A. Tobler 1995. Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J. Clin. Invest. 95: 973–979.
   PubMedGoogle Scholar
• Sellers, W. R., and W. G. Kaelin 1996. Rb as a modulator of transcription. Biochim. Biophys. Acta 1288: M1–M5.
   PubMedGoogle Scholar
• Shenk, T., and J. Flint 1991. Transcriptional and transforming activities of the adenovirus E1A proteins. Adv. Cancer Res. 57: 47–85.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1995. D-type cyclins. Trends Biochem. Sci. 20: 187–190.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274: 1672–1677.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149–1163.
   PubMed Web of Science ®Google Scholar
• Stillman, B. 1996. Cell cycle control of DNA replication. Science 274: 1659–1664.
   PubMed Web of Science ®Google Scholar
• Vlach, J., S. Hennecke, K. Alevizopoulos, D. Conti, and B. Amati 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15: 6595–6604.
   PubMed Web of Science ®Google Scholar
• Whyte, P. K. 1995. The retinoblastoma protein and its relatives. Semin. Cancer Biol. 6: 83–90.
   PubMed Web of Science ®Google Scholar
• Winston, J., F. Dong, and W. J. Pledger 1996. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J. Biol. Chem. 271: 11253–11260.
   PubMedGoogle Scholar
• Winston, J. T., S. R. Coats, Y. Z. Wang, and W. J. Pledger 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12: 127–134.
   PubMed Web of Science ®Google Scholar
• Won, K. A., and S. I. Reed 1996. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15: 4182–4193.
   PubMed Web of Science ®Google Scholar